enterovirus 71 vaccine
Jump to navigation
Jump to search
Indications
- immunization against enterovirus 71*
- children age 6-35 months[2]
* common cause of hand, foot, & mouth disease & other illnesses, including herpangina, viral meningitis, especially in the Asia-Pacific region
Dosage
- 2 IM injections 4 weeks apart
Notes
- vaccine efficacy is 95% against enterovirus 71 infection, & 100% in preventing hospitalization & & neurologic complications[2]
More general terms
References
- ↑ Zhu FC et al Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. May 29, 2013 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/23726161 <Internet> http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(13)61049-1/abstract
- ↑ 2.0 2.1 2.2 Zhu F et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med 2014 Feb 27; 370:818 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24571754 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1304923
Li R et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med 2014 Feb 27; 370:829. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24571755 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMoa1303224